Matches in SemOpenAlex for { <https://semopenalex.org/work/W2583582367> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2583582367 endingPage "S74" @default.
- W2583582367 startingPage "S74" @default.
- W2583582367 abstract "Liver-directed therapies for unresectable hepatocellular carcinoma (HCC) patients with advanced disease [Barcelona Clinic for Liver Cancer (BCLC) C] are increasingly employed. In this study, we aim to study the efficacy and prognostic indicators for BCLC C patients undergoing yttrium-90 radioembolization (Y90). With IRB approval, we searched our prospectively acquired database and included all BCLC C HCC patients that underwent Y90. The indication for BCLC C status [Eastern Cooperative Oncology Group (ECOG) performance status of 1 or 2, metastases, and/or portal vein thrombosis (PVT)] was recorded. Kaplan-Meier survival analyses were performed from the date of first Y90, censored to curative treatment, to calculate median overall survival (OS). Cox regression hazards model was used for multivariate analyses. Significance was set at P<0.05. 515 BCLC C patients were treated with Y90 with a median survival of 10.6 months (95% CI: 9.3-12.8). 189 patients (36.7%) were classified as BCLC C solely by their ECOG performance status; they had a median survival (95% CI) of 19.6 months (14.7-27). 326 patients (63.3%) were classified as BCLC C due to vascular invasion or metastases (regardless of ECOG performance status); they had an OS of 8 months (95% CI: 7.3-9) (P = 0.001). On multivariate analysis, ECOG was not found to be a statistically significant prognostic indicator of survival in BCLC C patients whereas metastasis and PVT had hazards ratios (95%CI) of 2.4 (1.8-3.1) and 3.2 (2.6-3.8), respectively (P<0.001). Radioembolization is an effective method of treating BCLC C HCC patients with median OS similar to that realized with currently allocated therapy per BCLC guidelines. Patients classified as BCLC C due to ECOG performance status alone demonstrated improved survival when compared to those presenting with PVT and/or metastases, regardless of ECOG. Hence, ECOG performance status by itself may not be a true indicator of advanced disease." @default.
- W2583582367 created "2017-02-10" @default.
- W2583582367 creator A5011003738 @default.
- W2583582367 creator A5033464248 @default.
- W2583582367 creator A5034174603 @default.
- W2583582367 creator A5045189584 @default.
- W2583582367 creator A5055996794 @default.
- W2583582367 creator A5064049623 @default.
- W2583582367 creator A5075153200 @default.
- W2583582367 creator A5087536545 @default.
- W2583582367 date "2017-02-01" @default.
- W2583582367 modified "2023-09-26" @default.
- W2583582367 title "Radioembolization of advanced HCC (BCLC C) patients: prognostic factors" @default.
- W2583582367 doi "https://doi.org/10.1016/j.jvir.2016.12.768" @default.
- W2583582367 hasPublicationYear "2017" @default.
- W2583582367 type Work @default.
- W2583582367 sameAs 2583582367 @default.
- W2583582367 citedByCount "0" @default.
- W2583582367 crossrefType "journal-article" @default.
- W2583582367 hasAuthorship W2583582367A5011003738 @default.
- W2583582367 hasAuthorship W2583582367A5033464248 @default.
- W2583582367 hasAuthorship W2583582367A5034174603 @default.
- W2583582367 hasAuthorship W2583582367A5045189584 @default.
- W2583582367 hasAuthorship W2583582367A5055996794 @default.
- W2583582367 hasAuthorship W2583582367A5064049623 @default.
- W2583582367 hasAuthorship W2583582367A5075153200 @default.
- W2583582367 hasAuthorship W2583582367A5087536545 @default.
- W2583582367 hasConcept C121608353 @default.
- W2583582367 hasConcept C126322002 @default.
- W2583582367 hasConcept C143998085 @default.
- W2583582367 hasConcept C2776231280 @default.
- W2583582367 hasConcept C2776907518 @default.
- W2583582367 hasConcept C2778019345 @default.
- W2583582367 hasConcept C2778800853 @default.
- W2583582367 hasConcept C2779033008 @default.
- W2583582367 hasConcept C38180746 @default.
- W2583582367 hasConcept C50382708 @default.
- W2583582367 hasConcept C71924100 @default.
- W2583582367 hasConcept C90924648 @default.
- W2583582367 hasConceptScore W2583582367C121608353 @default.
- W2583582367 hasConceptScore W2583582367C126322002 @default.
- W2583582367 hasConceptScore W2583582367C143998085 @default.
- W2583582367 hasConceptScore W2583582367C2776231280 @default.
- W2583582367 hasConceptScore W2583582367C2776907518 @default.
- W2583582367 hasConceptScore W2583582367C2778019345 @default.
- W2583582367 hasConceptScore W2583582367C2778800853 @default.
- W2583582367 hasConceptScore W2583582367C2779033008 @default.
- W2583582367 hasConceptScore W2583582367C38180746 @default.
- W2583582367 hasConceptScore W2583582367C50382708 @default.
- W2583582367 hasConceptScore W2583582367C71924100 @default.
- W2583582367 hasConceptScore W2583582367C90924648 @default.
- W2583582367 hasIssue "2" @default.
- W2583582367 hasLocation W25835823671 @default.
- W2583582367 hasOpenAccess W2583582367 @default.
- W2583582367 hasPrimaryLocation W25835823671 @default.
- W2583582367 hasRelatedWork W1992278374 @default.
- W2583582367 hasRelatedWork W1998259048 @default.
- W2583582367 hasRelatedWork W2367759171 @default.
- W2583582367 hasRelatedWork W2502435100 @default.
- W2583582367 hasRelatedWork W2753753279 @default.
- W2583582367 hasRelatedWork W2989603621 @default.
- W2583582367 hasRelatedWork W3083338011 @default.
- W2583582367 hasRelatedWork W3092660163 @default.
- W2583582367 hasRelatedWork W4308722554 @default.
- W2583582367 hasRelatedWork W4309660427 @default.
- W2583582367 hasVolume "28" @default.
- W2583582367 isParatext "false" @default.
- W2583582367 isRetracted "false" @default.
- W2583582367 magId "2583582367" @default.
- W2583582367 workType "article" @default.